Skip to main
OSCR

Oscar Health (OSCR) Stock Forecast & Price Target

Oscar Health (OSCR) Analyst Ratings

Based on 7 analyst ratings
Hold
Strong Buy 0%
Buy 14%
Hold 43%
Sell 29%
Strong Sell 14%

Bulls say

Oscar Health Inc. demonstrated a strong financial performance in the second quarter of 2025, with revenue reaching $2.86 billion, reflecting a year-over-year increase of 29% driven by robust retention and member growth. The company's medical loss ratio (MLR) improved significantly, coming in at 91.1%, which is 1200 basis points higher than the previous year and indicates effective health management despite increased market-wide morbidity. Additionally, Oscar Health projects substantial growth in enrollment weighted direct policy premiums, forecasting a 28.5% rise for calendar year 2026 and a 16.9% rise for 2027, underscoring a positive outlook for revenue expansion.

Bears say

Oscar Health is facing a challenging outlook due to projected declines in the mix of higher-margin Silver plans from 57.5% in 2026 to 51.0% in 2027, while lower-margin Bronze plans increase significantly, indicating potential revenue pressure. The anticipated expiration of E-APTCs by the end of 2025 could lead to a substantial drop in Individual ACA Marketplace enrollment, estimated between 20% to 30%, resulting in a loss of approximately 6.1 million lives from 2025 to 2026. Additionally, even though the SG&A ratio has improved, the adjusted EBITDA margin remains low at 2.4%, reflecting ongoing challenges in achieving profitability amidst declining enrollment and shifting plan dynamics.

Oscar Health (OSCR) has been analyzed by 7 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 14% recommend Buy, 43% suggest Holding, 29% advise Selling, and 14% predict a Strong Sell.

This aggregate rating is based on analysts' research of Oscar Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Oscar Health (OSCR) Forecast

Analysts have given Oscar Health (OSCR) a Hold based on their latest research and market trends.

According to 7 analysts, Oscar Health (OSCR) has a Hold consensus rating as of Dec 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $15.57, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $15.57, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Oscar Health (OSCR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.